TSXV - Delayed Quote CAD

BioNeutra Global Corporation (BGA.V)

0.1000 0.0000 (0.00%)
At close: April 19 at 3:55 PM EDT
Loading Chart for BGA.V
DELL
  • Previous Close 0.1000
  • Open 0.1000
  • Bid 0.1000 x --
  • Ask 0.1400 x --
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0050 - 0.1600
  • Volume 1,691
  • Avg. Volume 11,309
  • Market Cap (intraday) 4.67M
  • Beta (5Y Monthly) 1.95
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. BioNeutra Global Corporation is headquartered in Vancouver, Canada.

www.bioneutra.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: BGA.V

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BGA.V
400.00%
S&P/TSX Composite index
4.36%

1-Year Return

BGA.V
566.67%
S&P/TSX Composite index
5.70%

3-Year Return

BGA.V
63.64%
S&P/TSX Composite index
14.25%

5-Year Return

BGA.V
82.14%
S&P/TSX Composite index
31.66%

Compare To: BGA.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BGA.V

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    4.67M

  • Enterprise Value

    10.98M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.46

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.97

  • Enterprise Value/EBITDA

    -3.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -41.80%

  • Return on Assets (ttm)

    -13.20%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    11.27M

  • Net Income Avi to Common (ttm)

    -4.71M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    791.77k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.02M

Company Insights: BGA.V

People Also Watch